Benitec Biopharma (BNTC) Receivables - Net (2019 - 2025)

Benitec Biopharma (BNTC) reported Receivables - Net of $130000.0 for Q4 2025, up 1757.14% sequentially from $7000.0 in Q3 2025.

Benitec Biopharma (BNTC) Receivables - Net (2019 - 2025) Analysis & Trends

Benitec Biopharma (BNTC) has 7 years of Receivables - Net data on file, last reported at $130000.0 in Q4 2025.

For the quarter ending Q4 2025, Receivables - Net changed N/A year-over-year to $130000.0; the trailing twelve-month figure through Dec 2025 stood at $130000.0 (changed N/A YoY), and the FY2025 full-year result was $33000.0, down 85.59% from the prior year.
Receivables - Net grew to $130000.0 in Q4 2025, from $7000.0 in the prior quarter.
In the past five years, Receivables - Net ranged from a high of $229000.0 in Q2 2024 to a low of $3000.0 in Q3 2021.
A 5-year average of $42000.0 and a median of $25000.0 in 2021 frame the typical range for Receivables - Net.
Across the five-year window, Receivables - Net surged 1733.33% in 2023 and plunged 94.34% in 2025, its largest moves.
Tracing BNTC's Receivables - Net over 5 years: stood at $5000.0 in 2021, then surged by 1260.0% to $68000.0 in 2022, then fell by 22.06% to $53000.0 in 2023, then plunged by 92.45% to $4000.0 in 2024, then surged by 3150.0% to $130000.0 in 2025.
Business Quant data shows BNTC's Receivables - Net at $130000.0 in Q4 2025, $7000.0 in Q3 2025, and $33000.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Benitec Biopharma	46.45 Mn	46.45 Mn	-

Download Data